A Double Dose of Reform: Insurance and Centralized Negotiation in Drug Markets

Making innovative drugs affordable and accessible is a pressing global challenge. Centralized negotiation is an increasingly popular policy solution, but it remains understudied despite wide variation in implementation. This paper studies Chinas ongoing National Reimbursement Drug List (NRDL) Reform

搜集汇总

背景与挑战

背景概述

该数据集研究中国药品市场中的国家医保药品目录（NRDL）改革，聚焦于集中谈判政策如何应对创新药物的可负担性和可及性全球挑战。其特点在于分析中国这一具体案例，以探讨实施差异和未充分研究的集中谈判机制，旨在提供对政策效果的实证见解。